Acute liver disease: its causes and treatment (Q73263790)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13086026%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Acute liver disease: its causes and treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13086026%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

P KRAMER

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13086026%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

B FUCHS

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13086026%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 September 1953

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13086026%20AND%20SRC:MED&resulttype=core&format=json

Medical Clinics of North America

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13086026%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13086026%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

1379-1393

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13086026%20AND%20SRC:MED&resulttype=core&format=json

Recent advances in the knowledge of virus hepatitis.

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934956-2

Viral hepatitis; problems and progress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934956-2

PERIOD OF INFECTIVITY OF PATIENTS WITH EXPERIMENTALLY INDUCED INFECTIOUS HEPATITIS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934956-2

7 January 2021

Inoculation hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934956-2

The problem of prolonged hepatitis with particular reference to the cholangiolitic type and to the development of cholangiolitic cirrhosis of the liver.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934956-2

Certain pitfalls in liver function tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934956-2

Infectious hepatitis with subacute atrophy of the liver; an epidemic in women after the menopause

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934956-2

Liver function during infectious mononucleosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934956-2

The differential test for infectious mononucleosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934956-2

Leptospiral infections; a survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934956-2

Amebiasis of the liver; classification, diagnosis and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934956-2

Present status of gold therapy for rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934956-2

Effect of large doses of aureomycin on human liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934956-2

Fatal hepatorenal syndrome associated with phenurone therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934956-2

Acute yellow atrophy of the liver following treatment with phenylacetyl-urea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934956-2

Dilantin sensitivity; report of a case of hepatitis with jaundice, pyrexia and exfoliative dermatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934956-2

Hepatitis, exfoliative dermatitis and abnormal bone marrow occurring during tridione therapy; report of a case with recovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934956-2

Exfoliative dermatitis and hepatitis due to phenobarbital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934956-2

Toxic hepatitis from para-aminosalicylic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934956-2

Jaundice of hepatic origin during the course of methyl-testosterone therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934956-2

The hepatitis of hyperthermia report of a fatal case

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934956-2

The treatment of hepatic amebiasis with chloroquine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934956-2

The recognition and treatment of hepatic amebiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934956-2

PRIMAQUINE for vivax malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934956-2

10.1016/S0025-7125(16)34956-2

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13086026%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13086026%20AND%20SRC:MED&resulttype=core&format=json